Jérémie Guedj Selected Research

Ribavirin (Virazole)

1/2022	Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
1/2021	Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jérémie Guedj Research Topics

Disease

13	Infections 01/2024 - 01/2006
8	COVID-19 02/2024 - 01/2020
4	Neoplasms (Cancer) 04/2024 - 10/2019
4	Ebola Hemorrhagic Fever 01/2021 - 03/2016
3	Prostatic Neoplasms (Prostate Cancer) 07/2017 - 05/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 10/2023
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2023 - 12/2020
2	Carcinoma (Carcinomatosis) 01/2023 - 10/2019
2	Pneumonia (Pneumonitis) 01/2022 - 01/2022
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
2	Cytokine Release Syndrome 01/2021 - 10/2018
2	Human Influenza (Influenza) 01/2020 - 03/2016
2	Fever (Fevers) 01/2018 - 01/2017
2	Viremia 01/2017 - 03/2016
1	Hepatitis B 01/2023
1	Dysbiosis 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Hepatorenal Syndrome 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Lassa Fever (Fever, Lassa) 01/2021
1	Sepsis (Septicemia) 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Malaria 12/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2006

Drug/Important Bio-Agent (IBA)

13	favipiravirIBA 12/2021 - 03/2016
9	Antiviral Agents (Antivirals)IBA 09/2023 - 03/2016
5	atezolizumabIBA 04/2024 - 10/2019
3	remdesivirIBA 01/2022 - 10/2018
3	Prostate-Specific Antigen (Semenogelase)IBA 07/2017 - 05/2015
2	AntigensIBA 11/2023 - 01/2023
2	B7-H1 AntigenIBA 01/2023 - 10/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2022
2	Ribavirin (Virazole)FDA LinkGeneric 01/2022 - 01/2021
2	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2020 - 01/2017
1	tixagevimabIBA 02/2024
1	cilgavimab and tixagevimab drug combinationIBA 02/2024
1	cilgavimabIBA 02/2024
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 12/2023
1	tecovirimatIBA 12/2023
1	Neutralizing AntibodiesIBA 10/2023
1	InterferonsIBA 01/2023
1	Hepatitis B e AntigensIBA 01/2023
1	Viral RNAIBA 01/2023
1	Lamivudine (Epivir)FDA Link 01/2023
1	EnzymesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	molnupiravirIBA 12/2021
1	COVA1-18IBA 10/2021
1	NucleotidesIBA 01/2021
1	CytokinesIBA 01/2021
1	VaccinesIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	Mefloquine (Lariam)FDA LinkGeneric 12/2015
1	ArtesunateIBA 12/2015

Therapy/Procedure

6	Immunotherapy 04/2024 - 10/2019
5	Therapeutics 01/2024 - 01/2017
3	Drug Therapy (Chemotherapy) 10/2023 - 01/2017
2	Castration 07/2017 - 05/2015
1	Contraindications 01/2022
1	Phage Therapy 01/2022
1	Mechanical Ventilators (Ventilator) 01/2022
1	Personal Protective Equipment 01/2021
1	Highly Active Antiretroviral Therapy (HAART) 01/2006